Sion Medical Ltd
Ortal Cohen is an experienced professional in regulatory affairs and research and development, currently serving as VP of RA and R&D at Sion Medical Ltd since March 2020. Previously, Ortal held the position of RA Manager at Sion Biotext Medical Ltd from March 2017 to December 2020 and worked as a QA Investigator at Teva Pharmaceutical Industries Ltd from June 2012 to February 2017, where responsibilities included reviewing and approving out-of-specification (OOS) results, deviations, and non-conformance investigations while ensuring compliance with standard operating procedures. Additionally, Ortal worked as an investigator assistant at Ben Gurion University in late 2011. Ortal holds a Bachelor of Science degree in Chemical Engineering from Ben-Gurion University of the Negev, completed in 2012.
This person is not in any teams
This person is not in any offices
Sion Medical Ltd
Sion Medical Ltd. is a leading manufacturer of single-use skin cleansing and dermatologic treatment, advanced wound care, burns remedy and surgical solutions for the professional healthcare sector. Sion Medical Ltd. currently operates through 6 locations worldwide, 5 state-of-the-art production facilities, as well as two sales and logistic companies in Europe and in North America. The company has 4 decades of experience in the production of Medical Devices and OTC Drugs. Sion Medical Ltd. is on the front line of Advance Wound Care Management and Infection Prevention with a vast array of specialized products. The Sion Medical Group aim is to develop new innovative products that will influence, support and improve the quality of healthcare through the practice and management of infection control, wound management as well and the application of epidemiology in the healthcare settings. The Company's Quality System is accredited to ISO 9001:2015, EN ISO 13485:2016, and in compliance with CFR Title 21 Parts 210, 211, 820. Our products are registered in the EU with CE certification and in the US under the FDA.